Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.
- DOI
- 10.1007/s44164-025-00096-5
- Published
- 2025 Oct
- Container
- In vitro models
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s44164-025-00096-5,
title = {Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.},
author = {Muzard C and Seguin J and Bonnefoy J and Salkini N and Serra V and Alhareth K and Lemdani K and Mignet N},
year = {2025},
journal = {In vitro models},
doi = {10.1007/s44164-025-00096-5},
url = {https://doi.org/10.1007/s44164-025-00096-5}
}RIS
TY - JOUR TI - Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions. AU - Muzard C AU - Seguin J AU - Bonnefoy J AU - Salkini N AU - Serra V AU - Alhareth K AU - Lemdani K AU - Mignet N PY - 2025 JO - In vitro models DO - 10.1007/s44164-025-00096-5 UR - https://doi.org/10.1007/s44164-025-00096-5 ER -
APA
C, M., J, S., J, B., N, S., V, S., K, A., K, L., & N, M. (2025). Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.. In vitro models. https://doi.org/10.1007/s44164-025-00096-5
Source records
- pubmed · retrieved 2026-09-26T15:16:41.103Z
- europe-pmc · retrieved 2026-09-26T15:16:41.091Z